A Study of the Safety and Efficacy of EBV Specific T-cell Lines
Clinical trial NCT02580539 · COMPLETED
Trial details
- NCT number
- NCT02580539
- Sponsor
- Dr. Jean-Sebastien Delisle, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2025-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.